• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核受体辅调节因子PELP1/MNAR的功能与生物学特性

Functional and biological properties of the nuclear receptor coregulator PELP1/MNAR.

作者信息

Vadlamudi Ratna K, Kumar Rakesh

机构信息

Department of Obstetrics and Gynecology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.

出版信息

Nucl Recept Signal. 2007 May 17;5:e004. doi: 10.1621/nrs.05004.

DOI:10.1621/nrs.05004
PMID:17525794
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1876599/
Abstract

Proline-, glutamic acid-, and leucine-rich protein (PELP)1, also known as modulator of nongenomic actions of the estrogen receptor (MNAR), is a novel nuclear receptor coregulator with a multitude of functions. PELP1/MNAR serves as a scaffolding protein that couples various signaling complexes with nuclear receptors and participates in genomic and nongenomic functions. Recent data suggest that PELP1/MNAR expression is deregulated in several cancers, including breast, endometrial, prostate, and ovarian cancer, and that PELP1/MNAR interacts with several oncogenes. In this review, we summarize the emerging biological properties and functions of PELP1/MNAR.

摘要

富含脯氨酸、谷氨酸和亮氨酸的蛋白质(PELP)1,也被称为雌激素受体非基因组作用调节剂(MNAR),是一种具有多种功能的新型核受体共调节因子。PELP1/MNAR作为一种支架蛋白,将各种信号复合物与核受体偶联,并参与基因组和非基因组功能。最近的数据表明,PELP1/MNAR在包括乳腺癌、子宫内膜癌、前列腺癌和卵巢癌在内的几种癌症中表达失调,并且PELP1/MNAR与几种癌基因相互作用。在这篇综述中,我们总结了PELP1/MNAR新出现的生物学特性和功能。

相似文献

1
Functional and biological properties of the nuclear receptor coregulator PELP1/MNAR.核受体辅调节因子PELP1/MNAR的功能与生物学特性
Nucl Recept Signal. 2007 May 17;5:e004. doi: 10.1621/nrs.05004.
2
Emerging significance of ER-coregulator PELP1/MNAR in cancer.雌激素受体共调节因子PELP1/MNAR在癌症中的新意义
Histol Histopathol. 2007 Jan;22(1):91-6. doi: 10.14670/HH-22.91.
3
Role of PELP1/MNAR signaling in ovarian tumorigenesis.PELP1/MNAR信号通路在卵巢肿瘤发生中的作用。
Cancer Res. 2008 Jun 15;68(12):4902-9. doi: 10.1158/0008-5472.CAN-07-5698.
4
Comprehensive analysis of recent biochemical and biologic findings regarding a newly discovered protein-PELP1/MNAR.关于新发现的蛋白质PELP1/MNAR的近期生化和生物学研究结果的综合分析。
Clin Exp Metastasis. 2006;23(1):1-7. doi: 10.1007/s10585-006-9019-9. Epub 2006 Jul 7.
5
Proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor enhances androgen receptor functions through LIM-only coactivator, four-and-a-half LIM-only protein 2.富含脯氨酸、谷氨酸和亮氨酸的蛋白质-1/雌激素受体非基因组活性调节剂通过仅含LIM结构域的共激活因子、仅含四个半LIM结构域的蛋白质2增强雄激素受体功能。
Mol Endocrinol. 2007 Mar;21(3):613-24. doi: 10.1210/me.2006-0269. Epub 2006 Dec 27.
6
Oncogenic potential of the nuclear receptor coregulator proline-, glutamic acid-, leucine-rich protein 1/modulator of the nongenomic actions of the estrogen receptor.核受体辅调节因子富含脯氨酸、谷氨酸和亮氨酸蛋白1/雌激素受体非基因组作用调节因子的致癌潜力。
Cancer Res. 2007 Jun 1;67(11):5505-12. doi: 10.1158/0008-5472.CAN-06-3647.
7
Deregulation of estrogen receptor coactivator proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor in human endometrial tumors.人子宫内膜肿瘤中雌激素受体共激活因子富含脯氨酸、谷氨酸和亮氨酸蛋白-1/雌激素受体非基因组活性调节剂的失调。
J Clin Endocrinol Metab. 2004 Dec;89(12):6130-8. doi: 10.1210/jc.2004-0909.
8
Proline-, glutamic acid-, and leucine-rich protein-1 is essential in growth factor regulation of signal transducers and activators of transcription 3 activation.富含脯氨酸、谷氨酸和亮氨酸的蛋白-1在生长因子调节信号转导子和转录激活子3激活过程中至关重要。
Cancer Res. 2005 Jul 1;65(13):5571-7. doi: 10.1158/0008-5472.CAN-04-4664.
9
PELP1: A novel therapeutic target for hormonal cancers.PELP1:激素癌的新型治疗靶点。
IUBMB Life. 2010 Mar;62(3):162-9. doi: 10.1002/iub.287.
10
Modulation of in situ estrogen synthesis by proline-, glutamic acid-, and leucine-rich protein-1: potential estrogen receptor autocrine signaling loop in breast cancer cells.富含脯氨酸、谷氨酸和亮氨酸蛋白-1对原位雌激素合成的调节:乳腺癌细胞中潜在的雌激素受体自分泌信号环
Mol Endocrinol. 2008 Mar;22(3):649-64. doi: 10.1210/me.2007-0350. Epub 2007 Dec 13.

引用本文的文献

1
Steroid receptors and coregulators: Dissemination of sex differences and emerging technologies.类固醇受体与共调节因子:性别差异的传播及新兴技术
J Biol Chem. 2025 Apr;301(4):108363. doi: 10.1016/j.jbc.2025.108363. Epub 2025 Feb 27.
2
Expression of estrogen receptors, PELP1, and SRC in human spermatozoa and their associations with semen quality.雌激素受体、PELP1 和 SRC 在人精子中的表达及其与精液质量的关系。
Hum Cell. 2023 Mar;36(2):554-567. doi: 10.1007/s13577-022-00847-6. Epub 2022 Dec 28.
3
SETDB1 interactions with PELP1 contributes to breast cancer endocrine therapy resistance.

本文引用的文献

1
Oncogenic potential of the nuclear receptor coregulator proline-, glutamic acid-, leucine-rich protein 1/modulator of the nongenomic actions of the estrogen receptor.核受体辅调节因子富含脯氨酸、谷氨酸和亮氨酸蛋白1/雌激素受体非基因组作用调节因子的致癌潜力。
Cancer Res. 2007 Jun 1;67(11):5505-12. doi: 10.1158/0008-5472.CAN-06-3647.
2
Phosphorylation of MNAR promotes estrogen activation of phosphatidylinositol 3-kinase.MNAR的磷酸化促进雌激素对磷脂酰肌醇3激酶的激活。
Mol Cell Biol. 2007 Mar;27(5):1904-13. doi: 10.1128/MCB.01732-06. Epub 2006 Dec 28.
3
Proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor enhances androgen receptor functions through LIM-only coactivator, four-and-a-half LIM-only protein 2.
SETDB1 与 PELP1 的相互作用有助于乳腺癌内分泌治疗耐药。
Breast Cancer Res. 2022 Apr 8;24(1):26. doi: 10.1186/s13058-022-01520-4.
4
Clinical Evaluation of Proline, Glutamic acid, and Leucine-Rich Protein 1 Expression in Astrocytomas and Correlations with the Proliferation Marker Ki-67.星形细胞瘤中脯氨酸、谷氨酸和亮氨酸丰富蛋白 1 表达的临床评估及其与增殖标志物 Ki-67 的相关性。
J Mol Neurosci. 2021 Apr;71(4):724-733. doi: 10.1007/s12031-020-01690-w. Epub 2020 Sep 22.
5
PELP1 signaling contributes to medulloblastoma progression by regulating the NF-κB pathway.PELP1 信号通过调节 NF-κB 通路促进髓母细胞瘤的进展。
Mol Carcinog. 2020 Mar;59(3):281-292. doi: 10.1002/mc.23152. Epub 2019 Dec 24.
6
Ginsenoside Rg1 activates ligand-independent estrogenic effects via rapid estrogen receptor signaling pathway.人参皂苷Rg1通过快速雌激素受体信号通路激活非配体依赖性雌激素效应。
J Ginseng Res. 2019 Oct;43(4):527-538. doi: 10.1016/j.jgr.2018.03.004. Epub 2018 Mar 30.
7
The Clinical Value of PELP1 for Breast Cancer: A Comparison with Multiple Cancers and Analysis in Breast Cancer Subtypes.PELP1 在乳腺癌中的临床价值:与多种癌症的比较及乳腺癌亚型分析。
Cancer Res Treat. 2019 Apr;51(2):706-717. doi: 10.4143/crt.2018.316. Epub 2018 Aug 23.
8
Increased expression of PELP1 in human sperm is correlated with decreased semen quality.人精子中 PELP1 的表达增加与精液质量下降有关。
Asian J Androl. 2018 Sep-Oct;20(5):425-431. doi: 10.4103/aja.aja_11_18.
9
Role of Scaffold Protein Proline-, Glutamic Acid-, and Leucine-Rich Protein 1 (PELP1) in the Modulation of Adrenocortical Cancer Cell Growth.支架蛋白富含脯氨酸、谷氨酸和亮氨酸蛋白1(PELP1)在肾上腺皮质癌细胞生长调节中的作用。
Cells. 2017 Nov 7;6(4):42. doi: 10.3390/cells6040042.
10
PELP1: Structure, biological function and clinical significance.PELP1:结构、生物学功能及临床意义。
Gene. 2016 Jul 1;585(1):128-134. doi: 10.1016/j.gene.2016.03.017. Epub 2016 Mar 18.
富含脯氨酸、谷氨酸和亮氨酸的蛋白质-1/雌激素受体非基因组活性调节剂通过仅含LIM结构域的共激活因子、仅含四个半LIM结构域的蛋白质2增强雄激素受体功能。
Mol Endocrinol. 2007 Mar;21(3):613-24. doi: 10.1210/me.2006-0269. Epub 2006 Dec 27.
4
Emerging significance of ER-coregulator PELP1/MNAR in cancer.雌激素受体共调节因子PELP1/MNAR在癌症中的新意义
Histol Histopathol. 2007 Jan;22(1):91-6. doi: 10.14670/HH-22.91.
5
Comprehensive analysis of recent biochemical and biologic findings regarding a newly discovered protein-PELP1/MNAR.关于新发现的蛋白质PELP1/MNAR的近期生化和生物学研究结果的综合分析。
Clin Exp Metastasis. 2006;23(1):1-7. doi: 10.1007/s10585-006-9019-9. Epub 2006 Jul 7.
6
9-cis-retinoic acid up-regulates expression of transcriptional coregulator PELP1, a novel coactivator of the retinoid X receptor alpha pathway.9-顺式视黄酸上调转录共调节因子PELP1的表达,PELP1是类视黄醇X受体α途径的一种新型共激活因子。
J Biol Chem. 2006 Jun 2;281(22):15394-404. doi: 10.1074/jbc.M601593200. Epub 2006 Mar 30.
7
Membrane initiated estrogen signaling in breast cancer.乳腺癌中的膜启动雌激素信号传导
Biol Reprod. 2006 Jul;75(1):9-16. doi: 10.1095/biolreprod.105.050070. Epub 2006 Mar 29.
8
NXP-2 association with SUMO-2 depends on lysines required for transcriptional repression.NXP-2与SUMO-2的关联取决于转录抑制所需的赖氨酸。
Proc Natl Acad Sci U S A. 2006 Apr 4;103(14):5308-13. doi: 10.1073/pnas.0601066103. Epub 2006 Mar 27.
9
Altered localization of a coactivator sensitizes breast cancer cells to tumor necrosis factor-induced apoptosis.一种共激活因子的定位改变使乳腺癌细胞对肿瘤坏死因子诱导的凋亡敏感。
Mol Cancer Ther. 2006 Feb;5(2):230-7. doi: 10.1158/1535-7163.MCT-05-0276.
10
Novel mechanisms of resistance to endocrine therapy: genomic and nongenomic considerations.内分泌治疗耐药的新机制:基因组和非基因组方面的考量
Clin Cancer Res. 2006 Feb 1;12(3 Pt 2):1001s-1007s. doi: 10.1158/1078-0432.CCR-05-2110.